Muscle Weakness

Displaying 1 - 3 of 3CSV
Miotto, M. C., Luna-Figueroa, E., Tchagou, C., Bahlouli, L., Reiken, S., Dridi, H., Liu, Y., Weninger, G., & Marks, A. R. (2025). Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. Proceedings of the National Academy of Sciences, 122(24). https://doi.org/10.1073/pnas.2422082122
Publication Date
Pesini, A., Barriocanal-Casado, E., Compagnoni, G. M., Hidalgo-Gutierrez, A., Yanez, G., Bakkali, M., Chhonker, Y. S., Kleiner, G., Larrea, D., Tadesse, S., Lopez, L. C., Murry, D. J., Di Fonzo, A., Area-Gomez, E., & Quinzii, C. M. (2025). Coenzyme Q10 deficiency disrupts lipid metabolism by altering cholesterol homeostasis in neurons. Free Radical Biology and Medicine, 229, 441–457. https://doi.org/10.1016/j.freeradbiomed.2025.01.009
Publication Date
Horn, K. W., Shah, S. S., Skoll, D., Carter, D., Freeman, N. S., & Husain, S. A. (2024). The Case | Proximal muscle weakness, hypertension, and electrolyte abnormalities. Kidney International, 105(4), 895–896. https://doi.org/10.1016/j.kint.2023.10.015
Publication Date